Fundz

Who to call at Amylyx Pharmaceuticals, and when

Fundz watches for the moments Amylyx Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Amylyx Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Amylyx Pharmaceuticals, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchAmylyx Pharmaceuticals announces lifting of FDA hold on AMX0114 clinical trial to treat ALS.

Jan 21, 2025
CambridgeBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical

Product Description

Amylyx Pharmaceuticals has announced that the FDA has lifted the clinical hold on its Phase 1 trial for AMX0114, an investigational treatment for ALS. The company plans to open U.S. sites for the trial as well as initiate the Phase 1 LUMINA clinical trial in Canada in early 2025.

Company Information

Company

Amylyx Pharmaceuticals

Location

Cambridge, Massachusetts, United States

About

Amylyx Pharmaceuticals, Inc. is committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments. Amylyx is headquartered in Cambridge, Massachusetts and has operations in Canada and EMEA. For more information, visit amylyx.com and follow us on LinkedIn and Twitter. For investors, please visit investors.amylyx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Amylyx Pharmaceuticals ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Camille hidden

hidden
hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Amylyx Pharmaceuticals's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Amylyx Pharmaceuticals shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.